investor.sciclone.com investor.sciclone.com

investor.sciclone.com

SciClone Pharmaceuticals, Inc. - Investor Relations

Investors & Media. SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and. SciClone Corporate Presentation June, 2015. Jul 23, 2015. SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th. May 27, 2015. View all releases ».

http://investor.sciclone.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.SCICLONE.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.7 out of 5 with 11 reviews
5 star
4
4 star
2
3 star
4
2 star
0
1 star
1

Hey there! Start your review of investor.sciclone.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

FAVICON PREVIEW

  • investor.sciclone.com

    16x16

CONTACTS AT INVESTOR.SCICLONE.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
SciClone Pharmaceuticals, Inc. - Investor Relations | investor.sciclone.com Reviews
<META>
DESCRIPTION
Investors & Media. SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and. SciClone Corporate Presentation June, 2015. Jul 23, 2015. SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th. May 27, 2015. View all releases ».
<META>
KEYWORDS
1 about us
2 sitemap
3 business development
4 product portfolio
5 development portfolio
6 careers
7 investor relations
8 corporate profile
9 corporate governance
10 stock information
CONTENT
Page content here
KEYWORDS ON
PAGE
about us,sitemap,business development,product portfolio,development portfolio,careers,investor relations,corporate profile,corporate governance,stock information,analyst coverage,calendar of events,financial information,sec filings,proxy materials,more »
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

SciClone Pharmaceuticals, Inc. - Investor Relations | investor.sciclone.com Reviews

https://investor.sciclone.com

Investors & Media. SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and. SciClone Corporate Presentation June, 2015. Jul 23, 2015. SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th. May 27, 2015. View all releases ».

INTERNAL PAGES

investor.sciclone.com investor.sciclone.com
1

SciClone Pharmaceuticals, Inc. > Calendar of Events

http://investor.sciclone.com/events.cfm

Sciclone at China Conferences. Working at SciClone Corporate. Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Aug 9, 2016. Q2 2016 SciClone Pharmaceuticals, Inc. Earnings. May 10, 2016. Q1 2016 SciClone Pharmaceuticals, Inc. Earnings. Apr 13, 2016. 15th Annual Needham Healthcare Conference. Speaker: Wilson W. Cheung, Chief Financial Officer. Mar 10, 2016. Q4 2015 SciClone Pharmaceuticals, Inc. Earnings. Feb 9, 2016. Jan 13, 2016. Jan 11, 2016.

2

SciClone Pharmaceuticals, Inc. > Analyst Coverage

http://investor.sciclone.com/analysts.cfm

Sciclone at China Conferences. Working at SciClone Corporate. SciClone Pharmaceuticals, Inc. is covered by the following analysts. Jerry Isaacson, PhD. Notes Regarding Forward Looking Statements. 24180;赛生制药公司保留所有权利。请阅读我们的免责声明。 使用条款. 27880;意有关前瞻性陈述.

3

SciClone Pharmaceuticals, Inc. > Financials & Filings

http://investor.sciclone.com/financials.cfm

Sciclone at China Conferences. Working at SciClone Corporate. SciClone Reports Second Quarter 2016 Financial Results. SciClone Pharmaceuticals, Inc. Annual Report 2015. SciClone Pharmaceuticals, Inc. Proxy Statement. Mar 11, 2016. Mar 12, 2015. Aug 9, 2016. May 10, 2016. Notes Regarding Forward Looking Statements. 27880;意有关前瞻性陈述.

4

SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th (NASDAQ:SCLN)

http://investor.sciclone.com/releasedetail.cfm?ReleaseID=923441

Jul 23, 2015. SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th. FOSTER CITY, Calif. July 23, 2015. PRNewswire/ - SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the second quarter 2015 on. Monday, August 10, 2015. SciClone will host a conference call and webcast to provide a business and product update at. That day. The call will be hosted by. PhD, President and CEO, and. Wilson W. Cheung. And trade...

5

SciClone Pharmaceuticals, Inc. > Investors

http://investor.sciclone.com/index.cfm

Sciclone at China Conferences. Working at SciClone Corporate. SciClone Corporate Presentation August, 2016. Day High: 10.49. Day Low: 10.01. Aug 26, 2016. Delayed 20 min., by eSignal. There is no featured event at the moment. Aug 9, 2016. SciClone Reports Second Quarter 2016 Financial Results. Jul 28, 2016. SciClone Pharmaceuticals To Report Second Quarter 2016 Financial Results On August 9, 2016. View all press room ». Aug 9, 2016 at 4:30 PM ET. Q2 2016 SciClone Pharmaceuticals, Inc. Earnings.

UPGRADE TO PREMIUM TO VIEW 6 MORE

TOTAL PAGES IN THIS WEBSITE

11

LINKS TO THIS WEBSITE

sciclone.com sciclone.com

SciClone Pharmaceuticals, Inc. Marketed and Development Products

http://www.sciclone.com/product-portfolio

Sciclone at China Conferences. Working at SciClone Corporate. Ldquo;…it's not enough anymore just to have generics. That might work for the immediate future…but beyond that you need to have differentiated products if you want to remain or become a player in the pharmaceutical market.”. Dr Blobel on evolving China pharma market,. November 13, 2013. HBV, HCV, Cancer, Immune System Enhancer; Sepsis. We have built this attractive portfolio through targeted and successful partnering with leading pharmaceutica...

sciclone.com sciclone.com

SciClone Pharmaceuticals, Inc. NASDAQ:SCLN - Notes Regarding Forward Looking Statements

http://www.sciclone.com/notes-regarding-forward-looking-statements

Sciclone at China Conferences. Working at SciClone Corporate. Notes Regarding Forward Looking Statements. Notes Regarding Forward Looking Statements.

sciclone.com sciclone.com

About SciClone Pharmaceuticals, Inc. NASDAQ:SCLN

http://www.sciclone.com/about-us

Sciclone at China Conferences. Working at SciClone Corporate. Notes Regarding Forward Looking Statements.

sciclone.com sciclone.com

Careers at SciClone Pharmaceuticals, Inc.

http://www.sciclone.com/careers

Sciclone at China Conferences. Working at SciClone Corporate. At SciClone, we believe all our employees contribute directly to our growth and success. The progress we have made reflects the effort of the individuals who have come together to develop and commercialize important new treatments across multiple therapeutic areas. Notes Regarding Forward Looking Statements.

sciclone.com sciclone.com

Development Product Portfolio from SciClone Pharmaceuticals, Inc.

http://www.sciclone.com/development-portfolio

Sciclone at China Conferences. Working at SciClone Corporate. Neucardin™ is a novel, first-in-class therapeutic drug for the treatment of patients with intermediate to advanced chronic heart failure (CHF). It is a genetically engineered recombinant peptide fragment of neuregulin-1 that has been clinically shown to directly improve cardiac function, reverse ventricular remodeling and increase the survival of heart failure patients. Dr Blobel on ANGIOMAX,. December 24, 2014. ANGIOMAX and CLEVIPREX are part...

sciclone.com sciclone.com

SciClone Pharmaceuticals

http://www.sciclone.com/chinese

August 9, 2016. SciClone Reports Second Quarter 2016 Financial Results. July 28, 2016. SciClone Pharmaceuticals To Report Second Quarter 2016 Financial Results On August 9, 2016. July 19, 2016. SciClone Provides Update On Strategic Review Process. Notes Regarding Forward Looking Statements.

UPGRADE TO PREMIUM TO VIEW 26 MORE

TOTAL LINKS TO THIS WEBSITE

32

OTHER SITES

investor.sbiomed.com investor.sbiomed.com

Default Web Site Page

If you are the owner of this website, please contact your hosting provider: webmaster@investor.sbiomed.com. It is possible you have reached this page because:. The IP address has changed. The IP address for this domain may have changed recently. Check your DNS settings to verify that the domain is set up correctly. It may take 8-24 hours for DNS changes to propagate. It may be possible to restore access to this site by following these instructions. For clearing your dns cache.

investor.scasurgery.com investor.scasurgery.com

Investor Relations - Surgical Care Affiliates

Surgical Care Affiliates (SCA). We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Surgical Care Affiliates financial performance into perspective. Aug 11, 2015. Surgical Care Affiliates, Inc. Announces Closing of Secondary Public Offering of Common Stock. Aug 6, 2015. Surgical Care Affiliates, Inc. Announces Pricing of Secondary Public Offering of Common Stock. View all press releases ».

investor.schmitt-ind.com investor.schmitt-ind.com

Investors | Schmitt Industries, Inc. – IR Site

Skip to main navigation. Welcome to the investor relations page of the Schmitt Industries website. The Company's stock is traded under the symbol SMIT on the NASDAQ/CM Exchange. Schmitt Industries, Inc. Designs, manufactures and markets highly precise test and measurement systems for a wide variety of manufacturing, industrial and commercial applications. Technologies include vibration detection, acoustic emission analysis and surface roughness measurement for the grinding industry, dimensional and d...

investor.scholastic.com investor.scholastic.com

Investor Relations | Scholastic Corporation

Skip to main navigation. School / District Book Orders. Free Programs and Giveaways. Summer Reading Take Home. Play online with your kids ages 3-7. Parent and Child Magazine. Play online with your kids ages 3-7. School / District Book Orders. Stay Smart: Flu Resources. Scholastic Art and Writing. Community Programs, Awards and Grants. Other Corporate Initiatives and Programs. Education Sales Field Offices. Children’s Book Publishing and Distribution. Media, Licensing and Advertising. Party at the Store!

investor.schoolspecialty.com investor.schoolspecialty.com

All of the educational products you've come to know and trust - School Specialty, Inc. - Overview

Certificate of Incorporation (DE)-SSI Merger Sub Inc. Amended and Restated Certificate of Incorporation of SSI Merger Sub Inc. Code of Business Conduct/Ethics. School Specialty Announces the Election of New Independent Board Members. School Specialty's Classroom Direct(R) Outfits New York City's North Side School With Innovative, Collaborative Learning Furniture. School Specialty Announces Its Fiscal 2015 Fourth Quarter and Year-End Results. There are currently no events scheduled. 708 North Water Street.

investor.sciclone.com investor.sciclone.com

SciClone Pharmaceuticals, Inc. - Investor Relations

Investors & Media. SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and. SciClone Corporate Presentation June, 2015. Jul 23, 2015. SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th. May 27, 2015. View all releases ».

investor.sciquest.com investor.sciquest.com

Overview | SciQuest

Historic Stock Price Lookup. SciQuest (NASDAQ: SQI) spend management solutions enable procurement, sourcing and financial professionals to focus on strategic decisions that transform business processes. Our feature-rich products and expert services help hundreds of organizations, including leading global companies, drive bottom line results by improving, automating and optimizing their source-to-settle processes. To join the conversation, please visit the SciQuest Blog. Or follow us on Twitter @SciQuest.

investor.scotts.com investor.scotts.com

ScottsMiracle-Gro - Investor Relations - Investor Relations

Give Back to Gro. Media Images and Logos. Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Tuesday, August 04, 2015. 160;at 9:00 am ET. Q3 2015 The Scotts Miracle-Gro Company Earnings Conference Call. Tuesday, August 4, 2015 . 9:00 am ET  . Click here for webcast. Click here to add this event to your calendar. ScottsMiracle-Gro Announces Third Quarter Results; Re-Affirms Full-Year Earnings Outlook. The Scotts Miracle-Gro Company Increases Quarterly Dividend Payment. Scotts Smarter Solutio...

investor.sdchb.com investor.sdchb.com

SDCHB, LLC - Private Moneylending Opportunities

Put Your Money to Work. Learn how you can have your money work for you. Stop working for your money. Simply enter your information in the box below to learn theses groundbreaking high investment strategies that have the potential to change your entire financial future! We value your privacy and would never spam you. Review a quick Overview of the Investment Process:. Have Money to Invest. Considerations for investment: $5,000 – $50,000. You let your money grow for 3 – 6 months. Backed by Real Property.

investor.se investor.se

Welcome to Investor - Investor AB

Investor at a Glance. Listed holdings where we are lead owner. Long ownership horizon and value creation from dividends, value appreciation and cash flow. Our wholly-owned subsidiaries, partner-owned investments and other investments. Mölnlycke Health Care. Risk and Risk Management. Investor and Media Services. We have a long-term perspective for all investments. We always act in the best interest of our portfolio companies by fully supporting them in their efforts to create sustainable value. The Boards...